Skip to main content

College of
Health Sciences

Carlo Bartoli, MD, PhD

Assistant Professor

LOCATION(S)
Geisinger Medical Center
crbartoli@geisinger.edu

Carlo Bartoli, MD, PhD

Research Interests

Surgical management of congenital and acquired heart disease, artificial circulation, von Willebrand factor biology, angiogenesis.

Recent publications

  • Hennessy-Strahs S, Kang J, Krause E, Dowling RD, Rame J, BARTOLI CR. Patient-specific severity of von Willebrand factor degradation identifies LVAD patients at high risk for bleeding: A pilot study. Journal of Thoracic and Cardiovascular Surgery. 2022, In Press. 
  • Kawut SM, Krowka MJ, Forde KA, Al-Naamani N, Krok KL, Patel M, BARTOLI CR, Doyle M, Moutchia J, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB, for the Pulmonary Vascular Complications of Liver Disease Study Group. Impact of hepatopulmonary syndrome in liver transplant candidates and the role of angiogenesis. European Respiratory Journal. 2022, In Press. 
  • BARTOLI CR. Pathologic von Willebrand factor degradation is a major contributor to LVAD-associated bleeding: Pathophysiology and evolving clinical management. Annals of Cardiothoracic Surgery. 2021, 10(3) 389-392.
  • BARTOLI CR, Gohean JR, Smalling RW. Reinventing the displacement LVAD in the continuous-flow era: The TORVAD. Annals of Cardiothoracic Surgery. 2021, 10(2) 274-277. 
  • BARTOLI CR, Hennessy-Strahs S, Dowling RD, Gaynor JW, Glatz AC. Abnormalities in the von Willebrand-angiopoietin axis may contribute to dysregulated angiogenesis and angiodysplasia children with a Glenn circulation. Journal of the American College of Cardiology: Basic to Translational Science. 2021, 6(3) 222-235. 
  • Hennessy-Strahs S, Bermudez CA, Acker MA, Bartoli CR. Toward a standard practice to quantify von Willebrand factor degradation during left ventricular assist device support. Annals of Thoracic Surgery. 2020, Nov 20:S0003-4975(20)31935-4. 
  • BARTOLI CR, Kang J, Motomura T. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: Implications for device-specific management. Journal of Cardiac Surgery. 2020, 35(7): 1477-1483. 
  • BARTOLI CR, Hennessy-Strahs S, Gohean J, Villeda M, Larson E, Longoria R, Kurusz M, Acker MA, Smalling R. The TORVAD, a novel toroidal-flow LVAD minimizes blood trauma versus the HeartMate II: Implications of improved LVAD hemocompatibility. Annals of Thoracic Surgery. 2019, 107(6): 1761-1767. 
  • BARTOLI CR, Dowling RD. Next-generation mechanical circulatory support devices for the management of advanced heart failure. Cardiac Interventions Today. 2019, 13(1). 
  • Lawrence KM, Hennessy-Strahs S, McGovern PE, Mejaddam AY, Rossidis AC, Baumgarten HD, Bansal E, Villeda M, Rychik J, Peranteau WH, Davey MG, Flake AW, JW Gaynor, BARTOLI CR. Normoxic but not hypoxic extracorporeal support of the fetus in an artificial womb allows normal cardiac development. Journal of Clinical Investigation - Insight. 2018, 3(24). 
  • BARTOLI CR, Zhang D, Hennessy-Strahs S, Kang J, Restle D, Atluri P, Acker MA. Clinical and in vitro evidence that LVAD-induced von Willebrand factor degradation alters angiogenesis. Circulation: Heart Failure. 2018, 11(9). 
  • BARTOLI CR, Zhang D, Kang J, Hennessy-Strahs S, Restle D, Howard J, Redline G, Bermudez C, Atluri P, Acker MA. Clinical and ex vivo evidence that subclinical LVAD-associated hemolysis contributes to LVAD thrombosis. Annals of Thoracic Surgery. 2018, 105(3): 807-814. 
  • Kang J, Hennessy-Strahs S, Kwiatkowski P, Bermudez CA, Acker MA, Atluri P, McConnell PI, BARTOLI CR. Continuous-flow LVAD support causes a distinct form of intestinal angiodysplasia. Circulation Research. 2017, 121(8): 963-969. 
  • BARTOLI CR, Soucy K, Philips D, Giridharan G, Sobieski MA, Wead W, Dowling RD, Zhongjun JW, Prabhu S, Slaughter MS, Koenig SC. Continuous-flow left ventricular assist device support improves myocardial supply:demand in chronic heart failure. Annals of Biomedical Engineering. 2017, 45(6): 1475-1486. 
  • BARTOLI CR, Kang, J, Zhang D, Howard J, Acker MA, Atluri P, Motomura T. LVAD design reduces von Willebrand factor degradation: a comparative study between the HeartMate II and the EVAHEART left ventricular assist system. Annals of Thoracic Surgery. 2017, 103(4): 1239-1244. 
  • Flaherty MP, Pant S, Kilgore T, Dassanayaka S, Loughran JH, Rawasia W, B

Education

Cornell University
Harvard University
University of Louisville
University of Pennsylvania
Children's Hospital of Philadelphia

Additional Links

Content from General Links with modal content